Biomerica, Inc. (BMRA)

Biomerica Balance Sheet

Financials in millions USD. Fiscal year is June - May.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Cash & Equivalents	2.73	1.31	2.4	4.17	9.72	5.92
Cash & Short-Term Investments	2.73	1.31	2.4	4.17	9.72	5.92
Cash Growth	-10.48%	-45.48%	-42.47%	-57.09%	64.26%	40.90%
Receivables	0.9	0.79	0.73	0.95	0.72	0.77
Inventory	1.63	1.71	1.49	2.38	2.06	2.42
Prepaid Expenses	0.15	0.22	0.26	0.24	0.3	0.32
Total Current Assets	5.41	4.02	4.88	7.73	12.8	9.43
Property, Plant & Equipment	1.88	1.95	0.56	0.94	1.25	1.52
Long-Term Investments	0.5	0.5	0.17	0.17	0.17	0.17
Other Intangible Assets	0.2	0.21	0.23	0.21	0.17	0.17
Other Long-Term Assets	0.08	0.08	0.11	0.2	0.08	0.1
Total Assets	8.07	6.76	5.95	9.25	14.45	11.37

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Accounts Payable	1.5	0.38	0.3	0.56	0.34	0.74
Accrued Expenses	0.55	1.29	1.03	1.23	1.24	0.88
Short-Term Debt	0.5	0.5	-	-	-	-
Current Portion of Leases	0.24	0.24	0.36	0.33	0.3	0.34
Other Current Liabilities	0.05	0.08	0.06	0.09	0.06	0.05
Total Current Liabilities	2.84	2.48	1.74	2.2	1.95	2.01
Long-Term Leases	1.59	1.65	0.1	0.46	0.79	1.04
Total Liabilities	4.42	4.13	1.84	2.66	2.73	3.05

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Common Stock	0.37	0.26	0.2	0.17	1.35	1.03
Additional Paid-In Capital	61.57	59.43	57.18	54.72	52.71	42.45
Retained Earnings	-58.18	-56.94	-53.17	-48.2	-42.22	-35.08
Comprehensive Income & Other	-0.11	-0.11	-0.11	-0.1	-0.11	-0.07
Total Common Equity	3.65	2.63	4.11	6.59	11.72	8.33
Shareholders' Equity	3.65	2.63	4.11	6.59	11.72	8.33
Total Liabilities & Equity	8.07	6.76	5.95	9.25	14.45	11.37

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Total Debt	2.33	2.38	0.46	0.79	1.08	1.38
Net Cash (Debt)	0.41	-1.08	1.94	3.39	8.64	4.54
Net Cash Growth	-84.81%	-	-42.66%	-60.81%	90.33%	75.91%
Net Cash Per Share	0.13	-0.37	0.84	1.61	4.88	2.86
Filing Date Shares Outstanding	4.6	4.59	2.82	2.1	2.1	1.67
Total Common Shares Outstanding	4.6	3.2	2.55	2.1	2.1	1.61
Working Capital	2.57	1.54	3.14	5.53	10.85	7.42
Book Value Per Share	0.79	0.82	1.61	3.13	5.58	5.18
Tangible Book Value	3.44	2.42	3.88	6.38	11.56	8.16
Tangible Book Value Per Share	0.75	0.76	1.52	3.03	5.50	5.07
Machinery	-	1.58	1.6	1.6	1.54	1.52
Order Backlog	-	0.6	1.32	0.76	0.66	0.75

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error